Zavod za endokrinologiju
Klinike za unutrašnje bolesti
Medicinskog fakulteta Sveučilišta u Zagrebu
KBC Zagreb, Rebro

Kišpatićeva 12
TEL 01 2376 581 / FAX 01 2376 036
E-MAIL endokrinologija@kbc-zagreb.hr

Ikona sekcije


  1. Zibar Tomšić K, Dušek T, Kraljević I, Heinrich Z, Solak M, Vučinović A, Ozretić D, Mihailović Marasanov S, Hršak H, Kaštelan D. Hypopituitarism after gamma knife radiosurgery for pituitary adenoma. Endocr Res. 2017 May 24:1-7.
  2. Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Tabarin A, Krsek M, Fajardo C, Bolanowski M, Santos A, Wass JA, Trainer PJ; ERCUSYN Study Group. Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN. Eur J Endocrinol. 2017 May;176(5):613-624. 
  3. Misir Krpan A, Dusek T, Rakusic Z, Solak M, Kraljevic I, Bisof V, Ozretic D, Kastelan D. A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma. Case Rep Endocrinol. 2017;2017:2419590. 
  4. Vuk A, Baretic M, Osvatic MM, Filipcic I, Jovanovic N, Kuzman MR. Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review. J Clin Psychopharmacol. 2017 Oct;37(5):584-589.

  5. Vuk A, Kuzman MR, Baretic M, Osvatic MM. Diabetic ketoacidosis associated with antipsychotic drugs: case reports and a review of literature. Psychiatr Danub. 2017 Jun;29(2):121-135.

  6. Vrca Botica M, Carkaxhiu L, Kern J, Pavlić Renar I, Botica I, Zelić I, Iliev D, Vrca A. How to improve opportunistic screening by using EMRs and other data. The prevalence of undetected diabetes mellitus in target population in Croatia. Public Health. 2017 Apr;145:30-38. 

  7. Baretić M, Matovinović Osvatić M, Pavić E, Rabađija N, Uroić V, Koletić C, Rojnić Putarek N, Pavlić Renar I. Type 1 diabetes from adolescence to adulthood: is there a permanent need for nutrition education and reeducation? Minerva Endocrinol. 2017 Jan 31. 

  8. Djelmis J, Pavić M, Mulliqi Kotori V, Pavlić Renar I, Ivanisevic M, Oreskovic S. Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria. Int J Gynaecol Obstet. 2016 Dec;135(3):250-254. 


  10. Baretić M. Is denosumab a long-term option for the treatment of parathyroid carcinoma? QJM. 2016 Apr;109(4):288. 

  11. Reimondo G, Chiodini I, Puglisi S, Pia A, Morelli V, Kastelan D, Cannavo S, Berchialla P, Giachino D, Perotti P, Cuccurullo A, Paccotti P, Beck-Peccoz P, De Marchi M, Terzolo M. Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas. PLoS One. 2016 Sep 20;11(9):e0162437. 
  12. Ronchi CL, Di Dalmazi G, Faillot S, Sbiera S, Assié G, Weigand I, Calebiro D, Schwarzmayr T, Appenzeller S, Rubin B, Waldmann J, Scaroni C, Bartsch DK, Mantero F, Mannelli M, Kastelan D, Chiodini I, Bertherat J, Reincke M, Strom TM, Fassnacht M, Beuschlein F; European Network for the Study of Adrenocortical Tumors (ENSAT). Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation. J Clin Endocrinol Metab. 2016 Sep;101(9):3526-38. 
  13. Gulin T, Kruljac I, Kirigin L, Merc M, Pavić M, Trcin MT, Bokulić A, Megla ŽB, Kaštelan D. Advanced Age, High β-CTX Levels, and Impaired Renal Function are Independent Risk Factors for All-Cause One-Year Mortality in Hip Fracture Patients. Calcif Tissue Int. 2016 Jan;98(1):67-75. 
  14. Solak M, Kraljevic I, Dusek T, Melada A, Kavanagh MM, Peterkovic V, Ozretic D, Kastelan D. Management of Cushing's disease: a single-center experience. Endocrine. 2016 Mar;51(3):517-23.
  15. Hernández-Ramírez LC, Gabrovska P, Dénes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M; International FIPA Consortium. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54.
  16. Kastelan D, Kraljevic I, Dusek T, Knezevic N, Solak M, Gardijan B, Kralik M, Poljicanin T, Skoric-Polovina T, Kastelan Z. The clinical course of patients with adrenal incidentaloma: is it time to reconsider the current recommendations? Eur J Endocrinol. 2015 Aug;173(2):275-82. 
  17. Boban A, Zupancic Salek S, Kastelan D, Nemet D. Quantitative ultrasound and dual energy X-ray absorptiometry in the assessment of osteoporosis in patients with haemophilia. Haemophilia. 2014 Nov;20(6):e420-2. 
  18. Gornik I, Rahelić D, Husedzinović N, Gasparović V, Ivanović D, Krznarić Z, Pavlić-Renar I. Guidelines for the management of hyperglycaemia in hospitalised adult patients. Lijec Vjesn. 2014 Nov-Dec;136(11-12):315-23.

  19. Zgaga L, Vitart V, Hayward C, Kastelan D, Polasek O, Jakovljevic M, Kolcic I, Biloglav Z, Wright AF, Campbell H, Walker BR, Rudan I. Individual multi-locus heterozygosity is associated with lower morning plasma cortisol concentrations. Eur J Endocrinol. 2013 Jun 7;169(1):59-64. 
  20. Kaštelan D, Dušek T, Kraljević I, Aganović I. Hypercoagulable state in Cushing's syndrome is reversible following remission. Clin Endocrinol (Oxf). 2013; 78(1):102-6.
  21. Dušek T, Melada A, Paladino J, Kaštelan D. Transsphenoidal surgery for pituitary adenoma: indications and outcomes. Croat Med J. 2012;53:639-41.
  22. Dušek T, Kaštelan D, Melada A, Baretić M, Š koric Polovina T, Perković Z, Giljević Z, Jelčić J, Paladino J, Aganović I, Koršić M. Clinical features and therapeutic outcomes of patients with acromegaly: single centre experience. J Endocrinol Invest. 2011;34(11):e382-5.
  23. Kaštelan D, Džubur F, Dušek T, Poljičanin T, Crnčević-Orlic Z, Kraljević I, Solak M, Benčevic T, Aganović I, Knežević N, Kaštelan Z, Koršić M. Health-related quality of life and fatigue in patients with adrenal incidentaloma. Endocrine. 2011 Aug;40(1):84-9.
  24. Vlak T, Kaštelan D, Lozo P, Aljinović J, Gradišer M, Mijić S, Nikolić T, Miškić B, Car D, Tajšić G, Dušek T, Jajić Z, Grubišić F, Poljičanin T, Bakula M, Džubur F, Strižak-Ujević M, Kadojić M, Radman M, Vugrinec M, Kuster Z, Pekez M, Radović E, Labar L, Crnčević-Orlić Z, Koršić M. Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia. Clin Rheumatol 2011;30:1549-54.
  25. Gornik I, Vujaklija-Brajković A, Renar IP, Gašparović V. A prospective observational study of the relationship of critical illness associated hyperglycaemia in medical ICU patients and subsequent development of type 2 diabetes. Crit Care. 2010;14(4):R130. Erratum in: Crit Care. 2010;14(5):444.
  26. Kaštelan D, Vlak T, Lozo P, Gradišer M, Mijić S, Nikolić T, Miškić B, Car D, Tajsić G, Dušek T, Jajić Z, Grubišić F, Poljičanin T, Bakula M, Džubur F, Strizak-Ujević M, Kadojić M, Radman M, Vugrinec M, Kušter Z, Pekez M, Radović E, Labar L, Crnčević-Orlić Z, Koršić M. Health-related quality of life among patients with postmenopausal osteoporosis treated with weekly and monthly bisphosphonates. Endocr Res 2010;35:165-73.
  27. Kaštelan D, Koršić M, Kraljević I, Dušek T, Giljević Z, Koršić M. Low Serum 25-hydroxyvitamin D concentrations in healthy young males. J Endocrinol Invest. 2009;32(6):562-3.
  28. Kaštelan D, Dušek T, Kraljević I, Polašek O, Giljević Z, Solak M, Š alek SZ, Jelčić J, Aganović I, Koršić M. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine. 2009;36(1):70-4.
  29. Kaštelan D, Grubić Z, Kraljević I, Polašek O, Dušek T, Štingl K, Kerhin-Brkljačić V, Koršić M. The role of estrogen receptor-alpha gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations? J Bone Miner Metab. 2009;27(2):198-204.
  30. Dušek T, Kaštelan D, Solak M, Bašić Kinda S, Aganović I, Koršić M. Polycythemia as the first manifestation of Cushing's disease. J Endocrinol Invest. 2008;31(10):940.
  31. Kaštelan D, Koršić M, Vlak T. Ibandronate: is there an effect on nonvertebral fractures? Clin Rheumatol. 2008;27(10):1313-5.
  32. Kaštelan D, Grubić Z, Kraljević I, Durić K, Kardum I, Dušek T, Š tingl K, Giljević Z, Kerhin-Brkljačić V, Suchanek E, Koršić M. Decreased peak bone mass is associated with a 3-bp deletion/insertion of the CYP19 intron 4 polymorphism: preliminary data from the GOOS study. J Endocrinol Invest. 2007;30(6):465-9.
  33. Kaštelan D, Dušek T, Kraljević I, Polašek O, Perković Z, Kardum I, Giljević Z, Jelčić J, Aganović I, Koršić M. Bone properties in patients with acromegaly: quantitative ultrasound of the heel. J Clin Densitom. 2007;10(3):327-31.
  34. Turk N, Kaštelan D, Čukovic-Čavka S, Kraljević I, Koršić M, Vucelić B. Discriminatory ability of calcaneal quantitative ultrasound in the assessment of bone status in patients with inflammatory bowel disease. Ultrasound Med Biol. 2007;33(6):863-9.
  35. Kaštelan D, Kujundžić-Tiljak M, Kraljević I, Kardum I, Giljević Z, Koršić M. Calcaneus ultrasound in males: normative data in the Croatian population (ECUM study). J Endocrinol Invest. 2006;29(3):221-5.
  36. Dušek T, Koršić M, Koehler K, Perković Z, Huebner A, Koršić M. A novel AAAS gene mutation (p.R194X) in a patient with triple A syndrome. Horm Res. 2006;65(4):171-6.
  37. Kaštelan D, Dušek T, Vizner B, Gnjidić Z, Orlić ZC, Kušec V, Heinrich Z, Vrkljan M, Koršić M; Croatian Society of Endocrinology guidelines for the diagnosis and treatment of acromegaly. Lijec Vjesn. 2012;134(3-4):65-8.
  38. Kaštelan D, Dušek T, Aganović I, Š tern-Padovan R, Kuzmanić D, Kaštelan Z, Knežević N, Crnčević- Orlić Z, Kraljević I, Džubur F, Pavlić-Renar I, Giljević Z, Jelcić J, Baretić M, Š korić T, Koršić M. Management of adrenal incidentaloma: the position statement of the Croatian referral center for adrenal gland disorders]. Lijec Vjesn. 2010;132(3-4):71-5.
  39. Jelčić J, Baretić M, Koršić M; Fourth Croatian Congress on Obesity. [4th guidelines on diagnosis and treatment of obesity]. Lijec Vjesn. 2010;132(9-10):269-71.